JPH078790B2 - 腎保護持続注入液 - Google Patents

腎保護持続注入液

Info

Publication number
JPH078790B2
JPH078790B2 JP2500961A JP50096189A JPH078790B2 JP H078790 B2 JPH078790 B2 JP H078790B2 JP 2500961 A JP2500961 A JP 2500961A JP 50096189 A JP50096189 A JP 50096189A JP H078790 B2 JPH078790 B2 JP H078790B2
Authority
JP
Japan
Prior art keywords
renal
amino acid
solution
amino acids
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2500961A
Other languages
English (en)
Japanese (ja)
Other versions
JPH03502805A (ja
Inventor
ハーゲン ベルターマン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BETERMANN HAGEN
SKREZEK CHRISTIAN
Original Assignee
BETERMANN HAGEN
SKREZEK CHRISTIAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BETERMANN HAGEN, SKREZEK CHRISTIAN filed Critical BETERMANN HAGEN
Publication of JPH03502805A publication Critical patent/JPH03502805A/ja
Publication of JPH078790B2 publication Critical patent/JPH078790B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2500961A 1988-12-22 1989-12-21 腎保護持続注入液 Expired - Lifetime JPH078790B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3843241.2 1988-12-22
DE3843241A DE3843241A1 (de) 1988-12-22 1988-12-22 Nephroprotektive infusionsloesung
PCT/DE1989/000780 WO1990006769A1 (de) 1988-12-22 1989-12-21 Nephroprotektive infusionslösung

Publications (2)

Publication Number Publication Date
JPH03502805A JPH03502805A (ja) 1991-06-27
JPH078790B2 true JPH078790B2 (ja) 1995-02-01

Family

ID=6369857

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2500961A Expired - Lifetime JPH078790B2 (ja) 1988-12-22 1989-12-21 腎保護持続注入液

Country Status (8)

Country Link
EP (1) EP0408691B1 (enExample)
JP (1) JPH078790B2 (enExample)
AT (1) ATE110570T1 (enExample)
AU (1) AU4807990A (enExample)
DE (2) DE3843241A1 (enExample)
ES (1) ES2063332T3 (enExample)
RU (1) RU2077883C1 (enExample)
WO (1) WO1990006769A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6224776B1 (en) 1996-05-24 2001-05-01 Cultor Corporation Method for fractionating a solution
US6096785A (en) * 1996-07-30 2000-08-01 Novartis Nutrition Ag Amino acid compositions and use thereof in treating renal dysfunction
UA65587C2 (en) * 1997-10-09 2004-04-15 Baker Norton Pharma Method for preventing nephrotoxicity induced by cyclosporins or tacrolimus
NZ513926A (en) * 1999-02-23 2001-09-28 Univ California Methods of treatment of mitochondrial disorders
FI20010977A7 (fi) 2001-05-09 2002-11-10 Danisco Sweeteners Oy Kromatografinen erotusmenetelmä
PL206018B1 (pl) 2001-10-19 2010-06-30 Isotechnika Inc Preparat farmaceutyczny, sposób jego wytwarzania, mikroemulsja i zastosowanie tego preparatu farmaceutycznego
JPWO2005094813A1 (ja) * 2004-03-31 2008-02-14 味の素株式会社 腎疾患用薬剤
US9669010B2 (en) 2012-12-06 2017-06-06 Bio Health Solutions, Llc Treatment for chronic kidney disease
EP2928461B1 (en) * 2012-12-06 2019-08-21 Bio Health Solutions, LLC Treatment for chronic kidney disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3414491A1 (de) * 1984-04-17 1985-10-24 Hans Dr. 8202 Bad Aibling Dietl L-aminosaeurengemische fuer die parenterale und orale anwendung bei nierenerkrankungen

Also Published As

Publication number Publication date
JPH03502805A (ja) 1991-06-27
ES2063332T3 (es) 1995-01-01
AU4807990A (en) 1990-07-10
EP0408691B1 (de) 1994-08-31
ATE110570T1 (de) 1994-09-15
DE3843241C2 (enExample) 1990-11-22
RU2077883C1 (ru) 1997-04-27
EP0408691A1 (de) 1991-01-23
WO1990006769A1 (de) 1990-06-28
DE58908288D1 (de) 1994-10-06
DE3843241A1 (de) 1990-06-28

Similar Documents

Publication Publication Date Title
Nilsson Clinical pharmacology of aminocaproic and tranexamic acids
Shabani et al. Enhancement of wound repair with a topically applied nitric oxide‐releasing polymer
Denno et al. Glutamine-enriched total parenteral nutrition enhances plasma glutathione in the resting state
Maddrey et al. Effects of keto analogues of essential amino acids in portal-systemic encephalopathy
Tamada et al. The dipeptide alanyl‐glutamine prevents intestinal mucosal atrophy in parenterally fed rats
CA2176143A1 (en) Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
JPH09512552A (ja) 腎疾患および不全の治療方法ならびに組成物
WO2009004082A2 (en) Anticonvulsive pharmaceutical compositions
EP0318446A1 (en) Amino acid composition for parenteral nutritional support
Claris-Appiani et al. Lack of glomerular hemodynamic stimulation after infusion of branched-chain amino acids
JPH078790B2 (ja) 腎保護持続注入液
Peters et al. From rats to man: a perspective on dietary L-arginine supplementation in human renal disease.
Benigni et al. Renoprotection by nitric oxide donor and lisinopril in the remnant kidney model
Burns et al. Prevention of urinary catheter incrustations by acetohydroxamic acid
Opolon Large-pore hemodialysis in fulminant hepatic failure
US5290538A (en) Nephro protective infusion solutions
Fenier et al. Enalapril improved renal function and proteinuria in chronic glomerulopathies
EP0910361A1 (en) Use of an osmolyte for treating the effects of an infection, an inflammation or an immune dysfunction
JPH0116809B2 (enExample)
US6627659B1 (en) Methods of decreasing the effects of oxidative stress using N-acetylcysteine
Rivas-Cabañero et al. Effect of NG-Nitro-L· Arginine Methyl Ester on Nephrotoxicity Induced by Gentamicin in Rats
EP2163246A1 (en) Taurine or taurine-like substances for the prevention of the irreversible visual effects of vigabatrin
JPS6117520A (ja) 腎疾患の治療に有用なアンギオテンシン転換酵素阻害剤
Hübl et al. Importance of liver and kidney for the utilization of glutamine-containing dipeptides in man
Nakamoto et al. Role of nitric oxide in the evolution of renal ischemia in two-kidney, one-clip renovascular hypertension